AlemtuzumabAutoimmune diseases: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1846卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92265-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[21] Nivolumab/osimertinibInterstitial lung diseases: 3 case reports
Reactions Weekly, 2019, 1753 (1) : 262 - 262
[22] AlemtuzumabAutoimmune haemophagocytic lymphohistiocytosis: case report
Reactions Weekly, 2021, 1882 (1) : 31 - 31
[23] AlemtuzumabAutoimmune haemolytic anaemia: case report
Reactions Weekly, 2019, 1778 (1) : 21 - 21
[24] AlemtuzumabAutoimmune thyroid disorders: case report
Reactions Weekly, 2021, 1842 (1) : 18 - 18
[25] AlemtuzumabAutoimmune thyroid disease: case report
Reactions Weekly, 2019, 1767 (1) : 26 - 26
[26] TacrolimusDe novo inflammatory bowel diseases: 3 case reports
Reactions Weekly, 2013, 1456 (1) : 34 - 34
[27] AlemtuzumabAutoimmune haemolytic anaemia: case report
Reactions Weekly, 2016, 1601 (1) : 23 - 23
[28] DISEASES OF THE GUTTURAL POUCH IN THE HORSE - A REVIEW AND 3 CASE-REPORTS
DEBAERDEMAEKERPICAVET, T
VERSCHOOTEN, F
DEPREZ, P
SUSTRONCK, B
MUYLLE, E
DEMOOR, A
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 1992, 61 (02): : 36 - 41
[29] AlemtuzumabAutoimmune warm haemolytic anaemia: case report
Reactions Weekly, 2018, 1707 (1) : 24 - 24
[30] LenalidomideVarious toxicities: 3 case reports: 3 case reports
Reactions Weekly, 2021, 1836 (1) : 459 - 459

← 1 2 3 4 5 →